L627-1078 Screening compound: N-[(3,5-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

L627-1078 Screening compound: N-[(3,5-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide
L627-1078 Screening compound: N-[(3,5-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L627-1078
N-[(3,5-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L627-1078

Molecular Formula

C27H29F2N5O2 (C27 H29 F2 N5 O2)

Compound Name

N-[(3,5-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]methyl}benzamide

IUPAC name

N-[(35-difluorophenyl)methyl]-4-{[1-methyl-3-(pyrrolidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]methyl}benzamide

SMILES

Cn1nc(C(N2CCCC2)=O)c2c1CCN(Cc(cc1)ccc1C(NCc1cc(F)cc(F)c1)=O)C2

InChI

InChI=1S/C27H29F2N5O2/c1-32-24-8-11-33(17-23(24)25(31-32)27(36)34-9-2-3-10-34)16-18-4-6-20(7-5-18)26(35)30-15-19-12-21(28)14-22(29)13-19/h4-7,12-14H,2-3,8-11,15-17H2,1H3,(H,30,35)

InChI Key

FMYTXEUHFASWQN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27466127

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.805

Distribution Coefficient, logD

-3.515

Water Solubility, LogSw

-3.35

Polar Surface Area

60.078

Acid Dissociation Constant (pKa)

11.60

Base Dissociation Constant (pKb)

13.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

L627-1078 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Ion Channels Focused Library (26372 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Proteases
  • Ion Channels
Agro:
  • Agro

References: we are preparing a list of scientific research reports with L627-1078 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L627-1078?
Check Price and Availability of L627-1078, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L627-1078 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L627-1078
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L627-1078
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L627-1078 available by request